vs
Side-by-side financial comparison of ImmunityBio, Inc. (IBRX) and Mama's Creations, Inc. (MAMA). Click either name above to swap in a different company.
Mama's Creations, Inc. is the larger business by last-quarter revenue ($47.3M vs $38.3M, roughly 1.2× ImmunityBio, Inc.). Mama's Creations, Inc. runs the higher net margin — 1.1% vs -161.8%, a 162.9% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 50.0%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-71.3M).
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
IBRX vs MAMA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $38.3M | $47.3M |
| Net Profit | $-61.9M | $540.0K |
| Gross Margin | 99.0% | 23.6% |
| Operating Margin | -169.0% | 1.7% |
| Net Margin | -161.8% | 1.1% |
| Revenue YoY | 407.0% | 50.0% |
| Net Profit YoY | -4.7% | 31.7% |
| EPS (diluted) | $-0.06 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.3M | $47.3M | ||
| Q3 25 | $32.1M | $35.2M | ||
| Q2 25 | $26.4M | $35.3M | ||
| Q1 25 | $16.5M | $33.6M | ||
| Q4 24 | $7.6M | $31.5M | ||
| Q3 24 | $6.1M | $28.4M | ||
| Q2 24 | — | $29.8M | ||
| Q1 24 | — | $26.7M |
| Q4 25 | $-61.9M | $540.0K | ||
| Q3 25 | $-67.3M | $1.3M | ||
| Q2 25 | $-92.6M | $1.2M | ||
| Q1 25 | $-129.6M | $1.6M | ||
| Q4 24 | $-59.2M | $410.0K | ||
| Q3 24 | $-85.7M | $1.1M | ||
| Q2 24 | — | $553.0K | ||
| Q1 24 | — | $1.4M |
| Q4 25 | 99.0% | 23.6% | ||
| Q3 25 | 99.4% | 24.9% | ||
| Q2 25 | 99.5% | 26.1% | ||
| Q1 25 | 99.6% | 27.0% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 24.2% | ||
| Q2 24 | — | 25.0% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | -169.0% | 1.7% | ||
| Q3 25 | -173.5% | 4.8% | ||
| Q2 25 | -269.8% | 4.5% | ||
| Q1 25 | -390.1% | 5.7% | ||
| Q4 24 | -919.0% | 1.8% | ||
| Q3 24 | -1314.3% | 5.7% | ||
| Q2 24 | — | 2.6% | ||
| Q1 24 | — | 7.4% |
| Q4 25 | -161.8% | 1.1% | ||
| Q3 25 | -209.8% | 3.6% | ||
| Q2 25 | -350.3% | 3.5% | ||
| Q1 25 | -784.9% | 4.8% | ||
| Q4 24 | -783.4% | 1.3% | ||
| Q3 24 | -1404.0% | 4.0% | ||
| Q2 24 | — | 1.9% | ||
| Q1 24 | — | 5.3% |
| Q4 25 | $-0.06 | $0.01 | ||
| Q3 25 | $-0.07 | $0.03 | ||
| Q2 25 | $-0.10 | $0.03 | ||
| Q1 25 | $-0.15 | $0.04 | ||
| Q4 24 | $-0.08 | $0.01 | ||
| Q3 24 | $-0.14 | $0.03 | ||
| Q2 24 | — | $0.01 | ||
| Q1 24 | — | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $242.8M | $18.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-500.5M | $49.6M |
| Total Assets | $501.9M | $84.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $242.8M | $18.1M | ||
| Q3 25 | $257.8M | $9.4M | ||
| Q2 25 | $153.7M | $12.0M | ||
| Q1 25 | $61.6M | $7.2M | ||
| Q4 24 | $149.8M | $9.3M | ||
| Q3 24 | $130.4M | $7.4M | ||
| Q2 24 | — | $13.0M | ||
| Q1 24 | — | $11.0M |
| Q4 25 | $-500.5M | $49.6M | ||
| Q3 25 | $-524.3M | $29.6M | ||
| Q2 25 | $-570.7M | $26.4M | ||
| Q1 25 | $-591.4M | $24.9M | ||
| Q4 24 | $-489.1M | $23.0M | ||
| Q3 24 | $-745.1M | $22.3M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | — | $19.6M |
| Q4 25 | $501.9M | $84.0M | ||
| Q3 25 | $519.0M | $51.2M | ||
| Q2 25 | $402.1M | $52.7M | ||
| Q1 25 | $303.8M | $47.1M | ||
| Q4 24 | $382.9M | $47.9M | ||
| Q3 24 | $364.6M | $43.0M | ||
| Q2 24 | — | $47.2M | ||
| Q1 24 | — | $45.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-70.4M | $3.9M |
| Free Cash FlowOCF − Capex | $-71.3M | $3.7M |
| FCF MarginFCF / Revenue | -186.2% | 7.8% |
| Capex IntensityCapex / Revenue | 2.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 7.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-308.8M | $6.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-70.4M | $3.9M | ||
| Q3 25 | $-68.9M | $-1.7M | ||
| Q2 25 | $-79.7M | $6.0M | ||
| Q1 25 | $-85.9M | $-857.0K | ||
| Q4 24 | $-85.1M | $4.8M | ||
| Q3 24 | $-98.8M | $-2.4M | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $6.7M |
| Q4 25 | $-71.3M | $3.7M | ||
| Q3 25 | $-69.6M | $-2.2M | ||
| Q2 25 | $-80.8M | $5.5M | ||
| Q1 25 | $-87.0M | $-930.0K | ||
| Q4 24 | $-87.3M | $2.5M | ||
| Q3 24 | $-101.6M | $-4.0M | ||
| Q2 24 | — | $2.5M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | -186.2% | 7.8% | ||
| Q3 25 | -217.2% | -6.2% | ||
| Q2 25 | -305.9% | 15.5% | ||
| Q1 25 | -526.9% | -2.8% | ||
| Q4 24 | -1155.4% | 8.0% | ||
| Q3 24 | -1663.2% | -14.1% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 24.8% |
| Q4 25 | 2.4% | 0.4% | ||
| Q3 25 | 2.3% | 1.5% | ||
| Q2 25 | 4.1% | 1.5% | ||
| Q1 25 | 6.8% | 0.2% | ||
| Q4 24 | 28.0% | 7.2% | ||
| Q3 24 | 45.7% | 5.6% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | — | 7.16× | ||
| Q3 25 | — | -1.31× | ||
| Q2 25 | — | 4.85× | ||
| Q1 25 | — | -0.54× | ||
| Q4 24 | — | 11.71× | ||
| Q3 24 | — | -2.10× | ||
| Q2 24 | — | 6.58× | ||
| Q1 24 | — | 4.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
